We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Device Daily Bulletin Premium: Subscribe Now!
Email
Tweet

Device Daily Bulletin Premium: Subscribe Now!

Subscribe Now - Single-User

Device Daily Bulletin Premium

If the ever-changing medical device regulations and industry developments have done nothing but complicate your business, you need Device Daily Bulletin Premium. 

This new newsletter delivers precisely what you need to know, when you need to know it — each business day. It makes sense of everything successful devicemakers must know and do, delivering the news, analysis and interpretation of industry changes you need to stay in compliance and thrive.

For decades, top devicemakers relied on the insightful coverage of two of the industry’s most-trusted publications: The GMP Letter and International Devices & Diagnostics Monitor. The insights of these two information powerhouses have merged with the essential regularity of Device Daily Bulletin to become Device Daily Bulletin Premium.

All of this is reported and written by FDAnews’ team of experienced device industry journalists and subject matter experts. And it’s combined with timely content from FDAnews management reports and webinars.

Stay up to date on regulatory and legislative developments, along with actions taken by the current administration, FDA and other federal agencies that impact device development, manufacture, regulatory review and trials, and labeling and marketing.

Every business day Device Daily Bulletin Premium provides valuable insights into:

  • Breaking news on COVID-19 tests and devices, including approvals, launch of new products, research breakthroughs and recalls
  • Regulatory developments and new regulatory policies beyond FDA and other regulatory agency guidances
  • Device company mergers, especially when a company is acquiring a new technology or platform
  • Analyses of developments in the device industry
  • Developments on device labeling policies
  • FDA budgets and spending, including proposals and approvals by Congress and the president
  • FDA management and structure
  • Quality and GMP regulatory policies and developments in the industry
  • FDA inspection policies and schedules
  • FDA enforcement activities
  • Global enforcement trends
  • Pharmacovigilance developments in the EU and elsewhere
  • Recalls of existing products

Device Daily Bulletin Premium provides both breadth and depth of coverage in the daily frequency you need.

Subscribe today.

Start your single-user one-year subscription (250 issues) Device Daily Bulletin Premium for only $1,695.

Also available: Take advantage of our multi-user and site licenses of Device Daily Bulletin Premium, so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

We’re confident the value Device Daily Bulletin Premium provides you will pay for itself many times over. If you disagree, there’s our No-Risk, 100% Money-Back Guarantee: If at any time, for any reason, you become dissatisfied with Device Daily Bulletin Premium, you may cancel your subscription and receive a full refund. No questions asked.

Upcoming Events

  • 08Sep

    Organizing Data and Document Archives: Finding a Needle in a Haystack for FDA Inspections

  • 15Sep

    Califf’s Post-PDUFA, Post-COVID FDA Agenda: Key Developments, Insights and Analysis

  • 20Sep

    Building a World-Class Pharmaceutical Advertising and Promotion Review Program

  • 21Sep

    The FDA’s Focus on Clinical Data Integrity Throughout Product Development and Approval

  • 22Sep

    FDA’s New Quality Management System Regulation: What the Proposed Harmonization with ISO 13485 Means for Devicemakers

  • 11Oct

    1st Annual Quality Management vSummit

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Thermo Fisher Scientific Gets FDA Premarket Approval for Companion Diagnostic

  • MHRA Grants Conditional Authorization to Moderna’s Bivalent COVID-19 Booster Vaccine

  • Organogenesis Gets 510(k) Clearance to Expand PuraPly Portfolio

  • FDA Grants Priority Review to sNDA for Lynparza

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing